4. PE, DIC, stroke Flashcards
3 elements of hemostasis (Virchow)
- Endothelium
- Platelets
- Plasma
3 processes of hemostasis
- Primary: thrombocyte aggregation
- Secondary: coagulation, plasmatic cascade
- Tertiary: fibrinolysis
2 directions of hemostais
Pro/anti or clotting/bleeding
Fibrinogen concentration and substitution
2-4 g/L (no storage)
- Critical if less than 2 g/L
- Diluted by fluid resuscitation
- Substitution: fibrinogen conc. vs FFP
If hemostatic cascades are activated in the dynamic plasma:
DIC
Coaculation 3 (4) steps
- Initiation
- Amplification
- Propagation
- (Stabilisation)
Traditional basic/static lab tests in hemostasis
- PT/aPTT until 5 % throbin formation!
- Platelet, fibrinogen, antithrombin, d-dimer, aFXa
PT/INR vs aPTT
- PT: extrinsic coagulation
- aPTT: intrinsic coagulation
POC examples
- ROTEM/TEG
- Multiplate
Predisposing factors for DVT
- Patient-related (constitutional) or setting-related (transient)
- Provoked if occur within 6 weeks - 3 months
- Can be divided into strong, moderate or weak
Examples of strong predisposing factors for DVT
- Big trauma/surgery, knee/hip prosthesis
- Hospitalized within 3 months due to AMI, CHF, A-fib or A-flu
Examples of moderate predisposing factors for DVT
- Arthroscopic knee surgery, superficial venous thrombosis
- Transfusion, central venous line, chemotherapy!
- IBD, malignancy, infection, HF, oral contraceptives
Examples of weak predisposing factors for DVT
- Bed rest, immobility, varicosity
- Obesity, DM pregnancy etc
Definition and types of shock
Supply doesn´t meet demand (hypoperfusion)
1) Hypovolemic
2) Cardiogenic
3) Distributive
4) Obstructive
Initial risk stratification of PE
Shock or hypotension?
- Yes = high risk
- No = low risk
Clinical presentation PE
- Signs+symptoms, ECG, CXR, ABG
- Clinical probability scores (Geneva, Wells)
- Assess clinical probability (suspected/not suspected?)
Tests PE
- Lab (d-dimer)
- Imaging (CT, scint (V/Q), angio, MRA, echo, doppler)
Clinical probability scores PE
Geneva, Wells
ABG PE
- Typical: type I respiratory failure (hypoxemia+hypocapnia)
- But anything is possible
PE ECG syndrome
McGill-White syndrome: S1Q3T3
Signs of PE on CXR
- Westermark sign
- Hamptons hump (shows pulmonary infarction)
PE labs/biomarkers
- D-dimer
- BNP / NT-proBNP
- Troponin T/I, H-FABP
- (LDH) - outdated
CT triple rule out
AMI, aortic aneurysm, PE
Echo sign specific of PE
McConnell sign: free wall hypokinesis sparing the apex
PESI
Pulmonary embolism severity index (I-V)
Treatment of PE
High-risk: Primary reperfusion
Intermediate-risk
- Int-high: Anticoag, monitor, rescue reperfusion
- Int-low: Anticoag, hospitalization
Low-risk: Early discharge and home treatment if possible
Classification PE
- High mortality risk PE (high + intermediate-high)
- Non-high mortality risk PE (intermediate-low + low)
Systemic thrombolysis agents
- Streptokinase (250 000 IU iv)
- Urokinase (4400 IU/kg/10 min)
- rt-PA (100 mg/2h)
Absolute CI of thrombolytic therapy
- Hemorrhagic stroke or stroke of unknown origin (any time)
- Ischemic stroke (within 6 months)
- CNS damage or neoplasms
- Recent major trauma / surgery / head injury (within 3 weeks)
- GI bleeding (within 1 month)
- Known increased risk of bleeding
Anticoagulation in acute phase
- UFH
- LMWH
Anticoagulation subacute/chronic phase
- VKA
- LMWH, fondaparinux
- NOAC (DTI, DXI)
Surgical embolectomy
- If (sub) massive embolus, located centrally
- Thrombolysis is CI or ineffective
- Within 1 week
- Do a median sternotomy
- ECMO?
What is DIC?
- always a secondary disease
- an aquired syndrome
- intravascular activation of coagulation
- arising from different causes
- Can arise from and damage microvasculature
- Can produce organ dysfunction